Novel antiinflammatory targets for asthma. A role for PPARgamma?
Serhan
C N
CN
Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Pain and Perioperative Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. cnserhan@zeus.bwh.harvard.edu
Devchand
P R
PR
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000378:metabolism; D051379:Mice; D015230:Prostaglandin D2 / Q000031:analogs & derivatives / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000378:metabolism*; D012137:Respiratory System / Q000276:immunology*; D014157:Transcription Factors / Q000187:drug effects / Q000378:metabolism*
C097240:15-deoxy-delta(12,14)-prostaglandin J2; D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D015230:Prostaglandin D2